Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane COMPLETE in Dry Eye Patients Planning for Cataract Surgery
NCT06763731Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- May 2024
- Primary completion
- Jan 2027
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propylene glycol-hydroxypropyl guar nanoemulsion in dry eye syndrome (DED), sponsored by National Taiwan University Hospital. Primary endpoints: Ocular Surface Disease Index Dry Eye Questionnaire, Preoperative Assessments for Cataract Surgery: Vision Measurement and 3 more. Started May 2024; status: recruiting.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06763731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06763731.